Dr. Tsai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
310 East 14th Street
Administration Suite
New York, NY 10003Phone+1 212-979-4301Fax+1 212-979-4627
Summary
- Dr. James Tsai is the Delafield-Rodgers Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) in New York, NY, specializing in complex glaucoma-related disorders. He completed his medical education at Stanford University School of Medicine and received his residency training in ophthalmology at the University of Southern California (USC) and Los Angeles General Medical Center. He undertook glaucoma fellowships at the University of Miami/Bascom Palmer Eye Institute and Moorfields Eye Hospital/Institute of Ophthalmology (London, UK). Dr. Tsai holds prominent leadership roles, including President of The New York Eye and Ear Infirmary of Mount Sinai and System Chair of Ophthalmology and Founding Director of the Barry Family Center for Ophthalmic Artificial Intelligence and Human Health at Icahn Mount Sinai. Dr. Tsai has published extensively on glaucoma and related ophthalmic topics. He has received numerous accolades, including The Jacobi Medallion and the Dr. Sidney Grossman Distinguished Humanitarian Award from Icahn Mount Sinai, the Notable Health Care Leaders Award from Crain's New York Business, the Physician Scientist Award from Fight for Sight, and the Lifetime Achievement Honor Award from the American Academy of Ophthalmology.
Education & Training
- University of Miami Hospital and ClinicsFellowship, Glaucoma, 1993 - 1994
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 1990 - 1993
- Cedars-Sinai Medical CenterInternship, Internal Medicine, 1989 - 1990
- Stanford University School of MedicineClass of 1989
Certifications & Licensure
- FL State Medical License 1993 - 2027
- CA State Medical License 1990 - 2026
- CT State Medical License 2006 - 2025
- NY State Medical License 2001 - 2025
- TN State Medical License 1995 - 2007
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- The Jacobi Medallion Icahn School of Medicine at Mount Sinai, 2025
- Dr. Sidney Grossman Distinguished Humanitarian Award Icahn School of Medicine at Mount Sinai, 2023
- Notable Health Care Leaders Award Crain's New York Business, 2022
- Join now to see all
Clinical Trials
- A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma Start of enrollment: 2005 Jul 01
- Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002) Start of enrollment: 2011 Dec 01
- Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- Ophthalmic Drop Waste Due to Self-imposed Use Cessation Dates.John M Tan, Bo Chen, Daniel Vail, Alexander Barash, Min Jeong Jeon
Ophthalmology. 2024-11-01 - Using Multi-Layer Perceptron Driven Diagnosis to Compare Biomarkers for Primary Open Angle Glaucoma.Nicholas Riina, Alon Harris, Brent A Siesky, Lukas Ritzer, Louis R Pasquale
Investigative Ophthalmology & Visual Science. 2024-09-03 - Microinterventional system for robot-assisted gonioscopic surgery- technical feasibility and preclinical evaluation in synthetic eye models.Gautam Kamthan, Thijs Meenink, Isabella C Morgan, Andrew A Harvey, Jorge L Lince
BMC Ophthalmology. 2024-08-05
Press Mentions
- Schlemm Canal MicrostentingNovember 27th, 2024
- Mount Sinai Receives $5 Million Gift for the Center for Ophthalmic Artificial Intelligence and Human HealthOctober 16th, 2024
- Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi Targeting 80 Million Patient Encounters in the U.S. AnnuallyDecember 29th, 2020
- Join now to see all
Grant Support
- “Unrestricted Departmental Grant to Icahn School of Medicine at Mount Sinai”Reseach to Prevent Blindness, Inc.2014–2015
- “Unrestricted Departmental Grant to Icahn School of Medicine at Mount Sinai”Reseach to Prevent Blindness, Inc2013–2014
- A Prospective Observational Study Comparing the Effectiveness of Treatment Strategies for Primary Open-Angle GlaucomaNational Institutes of Health2011–2012
- Early Diagnosis of Glaucomatous Optic Neuropathy by VEP Testing for Rapid Objective Detection of Impairment of Specific Visual SubsystemNational Institutes of Health2004–2005
Committees
- Member, Special Emphasis Panel ZEY1-VSN (01),, National Eye Institute, National Institutes of Health 2015 - 2015
- Ministry of Health, Singapore, Member, National Medical Research Council (NMRC) International Expert Panel 2014 - 2016
- Member, Special Emphasis Panel ZEY1-VSN (01), National Eye Institute, National Institutes of Health 2014 - 2014
- Member, AUPO Task Force on Resident Education, Association of University Professors of Ophthalmology (AUPO) 2013 - 2014
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: